136 related articles for article (PubMed ID: 16736513)
1. Expression of epithelial membrane protein-2 is associated with endometrial adenocarcinoma of unfavorable outcome.
Wadehra M; Natarajan S; Seligson DB; Williams CJ; Hummer AJ; Hedvat C; Braun J; Soslow RA
Cancer; 2006 Jul; 107(1):90-8. PubMed ID: 16736513
[TBL] [Abstract][Full Text] [Related]
2. Radiation-associated endometrial cancers are prognostically unfavorable tumors: a clinicopathologic comparison with 527 sporadic endometrial cancers.
Pothuri B; Ramondetta L; Eifel P; Deavers MT; Wilton A; Alektiar K; Barakat R; Soslow RA
Gynecol Oncol; 2006 Dec; 103(3):948-51. PubMed ID: 16870239
[TBL] [Abstract][Full Text] [Related]
3. Epithelial membrane protein-2 expression is an early predictor of endometrial cancer development.
Habeeb O; Goodglick L; Soslow RA; Rao RG; Gordon LK; Schirripa O; Horvath S; Braun J; Seligson DB; Wadehra M
Cancer; 2010 Oct; 116(20):4718-26. PubMed ID: 20578181
[TBL] [Abstract][Full Text] [Related]
4. An intensive follow-up does not change survival of patients with clinical stage I endometrial cancer.
Gadducci A; Cosio S; Fanucchi A; Cristofani R; Genazzani AR
Anticancer Res; 2000; 20(3B):1977-84. PubMed ID: 10928137
[TBL] [Abstract][Full Text] [Related]
5. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
6. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
[TBL] [Abstract][Full Text] [Related]
7. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathologic analysis of 187 high-grade endometrial carcinomas of different histologic subtypes: similar outcomes belie distinctive biologic differences.
Soslow RA; Bissonnette JP; Wilton A; Ferguson SE; Alektiar KM; Duska LR; Oliva E
Am J Surg Pathol; 2007 Jul; 31(7):979-87. PubMed ID: 17592263
[TBL] [Abstract][Full Text] [Related]
9. The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinoma.
Alektiar KM; McKee A; Lin O; Venkatraman E; Zelefsky MJ; Mychalczak BR; McKee B; Hoskins WJ; Barakat RR
Cancer; 2002 Jul; 95(2):316-21. PubMed ID: 12124832
[TBL] [Abstract][Full Text] [Related]
10. Tumor-associated macrophages correlate with progesterone receptor loss in endometrial endometrioid adenocarcinoma.
Jiang XF; Tang QL; Li HG; Shen XM; Luo X; Wang XY; Lin ZQ
J Obstet Gynaecol Res; 2013 Apr; 39(4):855-63. PubMed ID: 23106983
[TBL] [Abstract][Full Text] [Related]
11. Significance of adenomyosis on tumor progression and survival outcome of endometrial cancer.
Matsuo K; Cahoon SS; Gualtieri M; Scannell CA; Jung CE; Takano T; Paulson RJ; Muderspach LI; Roman LD
Ann Surg Oncol; 2014 Dec; 21(13):4246-55. PubMed ID: 25001096
[TBL] [Abstract][Full Text] [Related]
12. Epithelial membrane protein-2 promotes endometrial tumor formation through activation of FAK and Src.
Fu M; Rao R; Sudhakar D; Hogue CP; Rutta Z; Morales S; Gordon LK; Braun J; Goodglick L; Wadehra M
PLoS One; 2011; 6(5):e19945. PubMed ID: 21637765
[TBL] [Abstract][Full Text] [Related]
13. Update on pathology, staging and molecular pathology of endometrial (uterine corpus) adenocarcinoma.
Rutgers JK
Future Oncol; 2015; 11(23):3207-18. PubMed ID: 26551559
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological significance of fragile histidine triad transcription protein expression in endometrial carcinomas.
Segawa T; Sasagawa T; Saijoh K; Inoue M
Clin Cancer Res; 2000 Jun; 6(6):2341-8. PubMed ID: 10873085
[TBL] [Abstract][Full Text] [Related]
15. Papillary serous and clear cell carcinoma limited to endometrial curettings in FIGO stage 1a and 1b endometrial adenocarcinoma: treatment implications.
Aquino-Parsons C; Lim P; Wong F; Mildenberger M
Gynecol Oncol; 1998 Oct; 71(1):83-6. PubMed ID: 9784324
[TBL] [Abstract][Full Text] [Related]
16. Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium.
Wadehra M; Forbes A; Pushkarna N; Goodglick L; Gordon LK; Williams CJ; Braun J
Dev Biol; 2005 Nov; 287(2):336-45. PubMed ID: 16216233
[TBL] [Abstract][Full Text] [Related]
17. [Prognostic factors in diagnosed endometrial cancers determining the type of radical surgery].
Ivanov S; Tomov S
Akush Ginekol (Sofiia); 2009; 48(3):14-9. PubMed ID: 20198758
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of morphometric nuclear grade of endometrial carcinoma.
Salvesen HB; Iversen OE; Akslen LA
Cancer; 1998 Sep; 83(5):956-64. PubMed ID: 9731900
[TBL] [Abstract][Full Text] [Related]
19. Adenomyosis is associated with myometrial invasion by FIGO 1 endometrial adenocarcinoma.
Ismiil ND; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Thomas G; Ackerman I; Covens A; Khalifa MA
Int J Gynecol Pathol; 2007 Jul; 26(3):278-83. PubMed ID: 17581412
[TBL] [Abstract][Full Text] [Related]
20. Adenomyosis involved by endometrial adenocarcinoma is a significant risk factor for deep myometrial invasion.
Ismiil N; Rasty G; Ghorab Z; Nofech-Mozes S; Bernardini M; Ackerman I; Thomas G; Covens A; Khalifa MA
Ann Diagn Pathol; 2007 Aug; 11(4):252-7. PubMed ID: 17630108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
